Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal paclitaxel plus systemic FOLFOX vs systemic FOLFOX for gastric cancer with peritoneal metastasis
KCT0010456Phase 3Recruiting
- Sponsor
- Korea Health Industry Development Institute
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, FOLFOX in gastric cancer (GC), sponsored by Korea Health Industry Development Institute. Started Aug 2025; status: recruiting.
02
Drugs
paclitaxelFOLFOX
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0010456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010456.